Integrating Molecular Subclassification of Medulloblastomas into Routine Clinical Practice: A Simplified Approach

scientific article published on 29 July 2015

Integrating Molecular Subclassification of Medulloblastomas into Routine Clinical Practice: A Simplified Approach is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/BPA.12293
P698PubMed publication ID26222673

P50authorSupriya MallickQ38546872
P2093author name stringChitra Sarkar
Aanchal Kakkar
Ashish Suri
Deepak Gupta
Vaishali Suri
Mehar C Sharma
Anupam Kumar
Pramod K Julka
Kavneet Kaur
P2860cites workMolecular subgroups of medulloblastoma: the current consensusQ24615271
Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN lociQ28236937
beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour CommitteeQ28279527
DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsiesQ28282708
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcomeQ28298987
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological featuresQ33366431
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomasQ34167499
Rapid diagnosis of medulloblastoma molecular subgroupsQ34764793
Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samplesQ35837393
Early recurrence in standard-risk medulloblastoma patients with the common idic(17)(p11.2) rearrangementQ36048155
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroupsQ36460209
Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular VariablesQ36476670
Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma.Q36631618
Genetic grouping of medulloblastomas by representative markers in pathologic diagnosisQ36865020
Medulloblastoma comprises four distinct molecular variantsQ36920479
Subgroup-specific prognostic implications of TP53 mutation in medulloblastomaQ36929844
Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor StudyQ37246499
Real-time PCR assay based on the differential expression of microRNAs and protein-coding genes for molecular classification of formalin-fixed paraffin embedded medulloblastomasQ37312706
Cytogenetic prognostication within medulloblastoma subgroupsQ37627692
International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and gradingQ38225758
Molecular stratification of medulloblastoma: comparison of histological and genetic methods to detect Wnt activated tumoursQ39181104
Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysisQ39828521
Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterationsQ40339027
Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group.Q42739353
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trialQ45120061
Treatment of early childhood medulloblastoma by postoperative chemotherapy aloneQ46367739
Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.Q47340801
Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study.Q48213578
Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients.Q53286039
Adult medulloblastoma comprises three major molecular variants.Q55463035
P433issue3
P304page(s)334-343
P577publication date2015-07-29
P1433published inBrain PathologyQ4955776
P1476titleIntegrating Molecular Subclassification of Medulloblastomas into Routine Clinical Practice: A Simplified Approach
P478volume26

Reverse relations

cites work (P2860)
Q64065929A simplified approach using Taqman low-density array for medulloblastoma subgrouping
Q51542148Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas.
Q48151439Expression of microRNAs in tumors of the central nervous system in pediatric patients in México
Q28079423Indian data on central nervous tumors: A summary of published work
Q51731284Medulloblastoma, WNT-activated/SHH-activated: clinical impact of molecular analysis and histogenetic evaluation.
Q42591772Next-generation sequencing of central nervous systems tumors: the future of personalized patient management
Q31145092Recent advances in subtyping tumors of the central nervous system using molecular data
Q41989047Risk factors for the prognosis of pediatric medulloblastoma: a retrospective analysis of 40 cases
Q38670567The Diagnostic Use of Immunohistochemical Surrogates for Signature Molecular Genetic Alterations in Gliomas
Q36288376Uniformity under in vitro conditions: Changes in the phenotype of cancer cell lines derived from different medulloblastoma subgroups
Q37391485Update on the integrated histopathological and genetic classification of medulloblastoma - a practical diagnostic guideline